The Clorox (CLX) Earnings Analysis
The Clorox (CLX) next reports earnings on 2026-08-03, consensus EPS 1.64 USD. Last quarter (2026-04-30) it beat with EPS 1.64 USD vs 1.55 USD est (+5.8%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 15.50.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLX next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | 1.64 USD |
| Revenue estimate | 1.91B |
CLX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 1.64 USD | 1.55 USD | +5.8% | Beat |
| 2025-11-03 | 0.85 USD | 0.818 USD | +3.9% | Beat |
| 2025-07-31 | 2.87 USD | 2.2 USD | +30.5% | Beat |
| 2025-05-05 | 1.45 USD | 1.55 USD | -6.5% | Miss |
| 2025-02-03 | 1.55 USD | 1.39 USD | +11.5% | Beat |
| 2024-08-01 | 1.82 USD | 1.56 USD | +16.7% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
CLX valuation and analyst view
| Trailing P/E | 15.50 |
|---|---|
| Trailing EPS | 6.229 USD |
| Price / book | -173.46 |
| Dividend yield | 5.18% |
| Market cap | 11.62B |
| Analyst consensus | Hold (4 buy / 20 hold / 5 sell) |
| Avg price target | 94.25 USD |
Related research pages
Frequently asked questions
When is The Clorox (CLX)'s next earnings date?
The Clorox is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 1.64 USD and revenue estimate of 1.91B.
Did CLX beat earnings last quarter?
In its 2026-04-30 report, CLX posted EPS of 1.64 USD versus a 1.55 USD estimate — a beat of 5.8%.
What is CLX's earnings track record?
Over the last 6 reported quarters with consensus data, CLX beat estimates 5 times (83%).
What is CLX's current P/E ratio and EPS?
CLX trades at a trailing P/E of 15.50 on trailing EPS of 6.229246145859941 USD.
What do analysts rate CLX?
Analyst consensus is "Hold" across 29 ratings (0 strong buy, 4 buy, 20 hold, 5 sell, 0 strong sell). Average 12-month price target: 94.25 USD.